Van Zyl GU, Jennings L, Rabie H, Orrell C, et al. Dolutegravir regimens have transformed treatment but ongoing drug resistance research is required to maintain success. AIDS 2024 Dec 23. doi: 10.1097/QAD.0000000000004099.
PMID: 39715045